BROWNSTEIN HYATT FARBER SCHRECK, LLP for ABBVIE
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2014 | $30,000 | Replaced |
| 3rd Quarter - Amendment | Jan 19, 2015 | $30,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S.2786-Corporate Inverters Earnings Stripping Reform Act of 2014 S.2360-Stop Corporate Inversions Act of 2014 H.R.4679-Stop Corporate Inversions Act of 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| MANUEL ORTIZ | — |
Health Issues HCR
H.R. 3723 - Viral Hepatitis Testing Act S. 2538 - Viral Hepatitis Testing Act Biosimilars
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATE MCCANLESS BLANKENBURG | — |
| LAURA JOHNSON BOLLIER | — |
| MARC LAMPKIN | — |
| ELIZABETH ANNE MAIER | — |
| ALFRED MOTTUR | — |
| MANUEL ORTIZ | — |
| ZACHARY PFISTER New | Legislative Intern-Sen. Evan Bayh |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.